Methods for treating cancer with hyperactive adar enzymes
US-2026077026-A1 · Mar 19, 2026 · US
This page is not indexed by search engines while we improve data quality.
Hubbell Jeffrey A patents
Hubbell Jeffrey A is listed as an inventor on 72 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Hubbell Jeffrey A |
| Total patents | 72 |
| First publication | Jan 21, 2016 |
| Latest publication | Mar 19, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Methods and compositions for treating cancer with cancer-binding adjuvants
US-2026053935-A1 · Feb 26, 2026 · US
Methods and compositions for treating cancer with ecm-affinity peptides linked to cytokines
US-2026049115-A1 · Feb 19, 2026 · US
Glycotargeting therapeutics
US-2026034226-A1 · Feb 5, 2026 · US
Glycotargeting therapeutics
US-2026007723-A1 · Jan 8, 2026 · US
Methods and compositions for treating inflammatory and autoimmune conditions with ecm-affinity peptides linked to anti-inflammatory agents
US-2025387480-A1 · Dec 25, 2025 · US
Methods and compositions for treating inflammatory and autoimmune conditions with ECM-affinity peptides linked to anti-inflammatory agents
US-12465640-B2 · Nov 11, 2025 · US
Antigen tolerance induction through use of flt3l variants
US-2025340607-A1 · Nov 6, 2025 · US
Glycotargeting therapeutics
US-2025295743-A1 · Sep 25, 2025 · US
Compositions and methods concerning immune tolerance
US-12383617-B2 · Aug 12, 2025 · US
Recent patents
Latest publications not already listed above.
Methods and compositions for treating cancer with ECM-affinity peptides linked to cytokines
US-12365714-B2 · Jul 22, 2025 · US
Erythrocyte-binding therapeutics
US-2025059263-A1 · Feb 20, 2025 · US
Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease
US-12186402-B2 · Jan 7, 2025 · US
Erythrocyte-binding therapeutics
US-2024279330-A1 · Aug 22, 2024 · US
Erythrocyte-binding therapeutics
US-12060414-B2 · Aug 13, 2024 · US
Methods and compositions for the treatment of wounds
US-2024092867-A1 · Mar 21, 2024 · US
Blockade of sars-cov-2 infection using hydrocarbon stapled peptides
US-2024052330-A1 · Feb 15, 2024 · US
Anti-inflammatory cytokines and methods of use
US-2024052006-A1 · Feb 15, 2024 · US
Targeted, intracellular delivery of therapeutic peptides using supramolecular nanomaterials
US-2024033373-A1 · Feb 1, 2024 · US
Erythrocyte-binding therapeutics
US-11884721-B2 · Jan 30, 2024 · US
Methods and compositions for treating cancer with ecm-affinity peptides linked to immunotherapeutic antibodies
US-2023377764-A1 · Nov 23, 2023 · US
Glycotargeting therapeutics
US-11801305-B2 · Oct 31, 2023 · US
Glycotargeting therapeutics
US-11793882-B2 · Oct 24, 2023 · US
Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease
US-2023293703-A1 · Sep 21, 2023 · US
Methods and compositions for the treatment of wounds
US-11732029-B2 · Aug 22, 2023 · US
Glycotargeting therapeutics
US-11666638-B2 · Jun 6, 2023 · US
Glycotargeting therapeutics
US-11654188-B2 · May 23, 2023 · US
Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease
US-11633486-B2 · Apr 25, 2023 · US
Glycotargeting therapeutics
US-2023119325-A1 · Apr 20, 2023 · US
Glycotargeting therapeutics
US-2023115331-A1 · Apr 13, 2023 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ecole Polytechnique Fed Lausanne Epfl | 36 |
| Univ Chicago | 34 |
| Anokion Sa | 11 |
| Imperial College Innovations Ltd | 2 |
| Ecole Polytechnique Fed De Lausanne (Epfl) | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K39/001 | 41 |
| A61K38/00 | 31 |
| A61K47/549 | 31 |
| A61K39/0008 | 30 |
| A61K39/35 | 28 |